Clinical relevance of proteinase activated receptors (PARs) in the gut

Gut

Volumn 54, Issue 6, 2005, Pages 867-874

  Vergnolle, N ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; RECEPTOR SUBTYPE;

CELL MEMBRANE PERMEABILITY; CHLORIDE TRANSPORT; COLITIS; COLON CANCER; COLON CARCINOGENESIS; ENTERITIS; ENZYME ACTIVATION; GASTROINTESTINAL TRACT FUNCTION; HUMAN; INTESTINAL FIBROSIS; INTESTINE MOTILITY; ION TRANSPORT; IRRITABLE COLON; MITOGENESIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SENSORY NERVE; SIGNAL TRANSDUCTION; SMALL INTESTINE; STOMACH; TUMOR GROWTH;

CELL PROLIFERATION; COLITIS; COLONIC NEOPLASMS; GASTRITIS; GASTROINTESTINAL MOTILITY; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; ION TRANSPORT; IRRITABLE BOWEL SYNDROME; MUSCLE CONTRACTION; NEURONS, AFFERENT; PERMEABILITY; RECEPTORS, PROTEINASE-ACTIVATED;

EID: 19544392708     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.048876     Document Type: Review

References (57)

1. Vergnolle N. Modulation of visceral pain and inflammation by protease-activated receptors. Br J Pharmacol 2004;141:1264-74.
2. Mule F, Pizzuti R, Capparelli A, et al. Evidence for the presence of functional protease activated receptor 4 (PAR(4)) in the rat colon. Gut 2004;53:229-34.
3. Buresi MC, Schleihauf E, Vergnolle N, et al. Protease-activated receptor-1 stimulates Ca(2+)-dependent Cl(-) secretion in human intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2001;281:G323-32.
4. Kong W, McConalogue K, Khitin L, et al. Luminal trypsin may regulate enterocytes through proteinase-activated receptor-2. Proc Natl Acad Sci U S A 1997;94:8884-9.
5. Green BT, Bunnett NW, Brown DR. Type 2 protease-activated receptor (PAR-2) in porcine ileal mucosa. Neuroregulation of active ion transport and modulation by d-opiod receptors. FASEB J 1999;13:A733.
6. Vergnolle N, Macnaughton WK, Al-Ani B, et al. Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport. Proc Natl Acad Sci U S A 1998;95:7766-71S.
7. Cuffe JE, Bertog M, Velazquez-Rocha S, et al. Basolateral PAR-2 receptors mediate KCl secretion and inhibition of Na(+) absorption in the mouse distal colon. J Physiol 2002;539:209-22.
8. Mall M, Gonska T, Thomas J, et al. Activation of ion secretion via proteinase-activated receptor-2 in human colon. Am J Physiol Gastrointest Liver Physiol 2002;282:G200-10.
9. Cenac N, Coelho A, Nguyen C, et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol 2002;161:1903-15.
10. Chin AC, Verqnolle N, Macnaughton WK, et al. Proteinase-activated receptor-1 induces apoptosis and increases intestinal permeability. Proc Natl Acad Sci U S A 2003;100:11104-9.
11. Cenac N, Garcia-Villar R, Ferrier L, et al. Proteinase-activated receptor-2-induced colonic inflammation in mice: possible involvement of afferent neurons, nitric oxide, and paracellular permeability. J Immunol 2003;170:4296-300.
12. Vergnolle N. Review article: proteinase-activated receptors-novel signals for gastrointestinal pathophysiology. Aliment Pharmacol Ther 2000;14:257-66.
13. Saifeddine M, Al-Ani B, Cheng C, et al. Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides and in gastric and vascular tissues. Br J Pharmacol 1996;118:521-30.
14. Cocks TM, Sozzi V, Moffatt JD, et al. Protease-activated receptors mediate apamin-sensitive relaxation of mouse and guinea pig gastrointestinal smooth muscle. Gastroenterology 1999;116:586-92.
15. Corvera CU, Dery O, McConalogue K, et al. Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. J Clin Invest 1997;100:1383-93.
16. Mule F, Baffi MC, Cerra MC. Dual effect mediated by protease-activated receptors on the mechanical activity of rat colon. Br J Pharmacol 2002;136:367-74.
17. Mule F, Baffi MC, Falzone M, et al. Signal transaction pathways involved in the mechanical responses to protease-activated receptors in rat colon. J Pharmacol Exp Ther 2002;303:1265-72.
18. Kawabata A, Kuroda R, Nagata N, et al. In vivo evidence that protease-activated receptors 1 and 2 modulate gastrointestinal transit in the mouse. Br J Pharmacol 2001;133:1213-18.
19. Gao CY, Liu SM, Hu HZ, et al. Serine proteases excite myenteric neurons through protease-activated receptors in guinea pig small intestine. Gastroenterology 2002;123:1554-64.
20. Linden DR, Manning BP, Bunnett NW, et al. Agonists of proteinase-activated receptor 2 excite guinea pig ileal myenteric neurons. Eur J Pharmacol 2001;431:311-14.
21. Zhao A, Shea-Donohue T. PAR-2 agonists induce contraction of murine small intestine through neurokinin receptors. Am J Physiol Gastrointest Liver Physiol 2003;285:G696-703.
22. Vergnolle N, Cellars L, Mencarelli A, et al. Proteinase-activated receptor-1: a role in inflammatory bowel diseases. J Clin Invest 2004;114:1444-56.
23. Nguyen C, Coelho A, Grady EF, et al. Proteinase-activated receptor-2-induced colitis is mediated by a neurogenic mechanism. Can J Physiol Pharmacol 2003;81:920-7.
24. Collins SM. Altered neuromuscular function in the inflamed bowel. In: Kirsner JB, ed. Inflammatory bowel diasease. Philadelphia: Saunders WB, 2000.
25. Mazelin L, Theodorou V, Fioramonti J, et al. Vagally dependent protective action of calcitonin gene-related peptide on colitis. Peptides 1999;20:1367-74.
26. McCafferty DM, Wallace JL, Sharkey KA. Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat. Am J Physiol 1997;272:G272-80.
27. Fiorucci S, Mencarelli A, Palazzetti B, et al. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci U S A 2001;98:13936-41.
28. Klarenbach SW, Chipiuk A, Nelson RC, et al. Differential actions of PAR2 and PAR1 in stimulating human endothelial cell exocytosis and permeability: the role of Rho-GTPases. Circ Res 2003;92:272-8.
29. Vouret-Craviari V, Grall D, Van Obberghen-Schilling E. Modulation of Rho GTPase activity in endothelial cells by selective proteinase-activated receptor (PAR) agonists. J Thromb Haemost 2003;1:1103-11.
30. Coelho AM, Vergnolle N, Guiard B, et al. Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. Gastroenterology 2002;122:1035-47.
31. Reed DE, Barajas-Lopez C, Cottrell G, et al. Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea pig submucosal neurons. J Physiol 2003;547:531-42.
32. Kirkup AJ, Jiang W, Bunnett NW, et al. Stimulation of proteinase-activated receptor 2 excites jejunal afferent nerves in anaesthetised rats. J Physiol 2003;552:589-601.
33. Coelho A, Bunnett NW. Intestinal activation of proteinase-activated receptor-1 (PAR1) reduces visceral nociception associated to rectal distension (RD) in rats. Gastroenterology 2003;124:A1.
34. Vergnolle N, Cellars L, Chapman K. Proteinase-activated receptor-1 agonists attenuate visceral pain. Gastroenterology 2003;124:A252.
35. Asfaha S, Brussee V, Chapman K, et al. Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br J Pharmacol 2002;135:1101-6.
36. Darmoul D, Marie JC, Devaud H, et al. Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2. Br J Cancer 2001;85:772-9.
37. Darmoul D, Gratio V, Devaud H, et al. Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am J Pathol 2003;162:1503-13.
38. Shi X, Gangadharan B, Brass LF, et al. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res 2004;2:395-402.
39. Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev 2004;3:394-400.
40. Wakefield AJ, Sawyerr AM, Dhillon AP, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989;2:1057-62.
41. Thompson NP, Wakefield AJ, Pounder RE. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 1995;108:1011-15.
42. Kim JA, Choi SC, Yun KJ, et al. Expression of protease-activated receptor 2 in ulcerative colitis. Inflamm Bowel Dis 2003;9:224-9.
43. Marchbank T, Chinery R, Handy A, et al. Distribution and expression of pancreatic secretory trypsin inhibitor and its possible role in epithelial restitution. Am J Pathol 1996;148:715-22.
44. Marchbank T, Freeman TC, Playford RJ. Human pancreatic secretory trypsin inhibitor. Distribution, actions and possible role in mucosal integrity and repair. Digestion 1998;59:167-74.
45. Playford RJ, Hanby AM, Patel K, et al. Influence of inflammatory bowel disease on the distribution and concentration of pancreatic secretory trypsin inhibitor within the colon. Am J Pathol 1995;146:310-16.
46. Fernandez M, Auyeung KJ, Madden K, et al. Nematode infection alters protease-activated receptor (PAR)-induced epithelial cell responses in murine small intestine. Gastroenterology 2003;124:A-83.
47. Lourbakos A, Potempa J, Travis J, et al. Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun 2001;69:5121-30.
48. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2003;84:579-621.
49. Spiller RC. Role of nerves in enteric infection. Gut 2002;51:759-62.
50. Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 2002;122:2032-48.
51. Collins SM, Piche T, Rampal P. The putative role of inflammation in the irritable bowel syndrome. Gut 2001;49:743-5.
52. Collins SM. Peripheral mechanisms of symptom generation in irritable bowel syndrome. Can J Gastroenterol 2001;15(suppl B):14-6B.
53. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-11.
54. Barau E, Dupont C. Modifications of intestinal permeability during food provocation procedures in pediatric irritable bowel syndrome. J Pediatr Gastroenterol Nutr 1990;11:72-7.
55. Camerer E, Qazi AA, Duong DN, et al. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 2004;104:397-401.
56. Chambers RC, Leoni P, Blanc-Brude OP, et al. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem 2000;275:35584-91.
57. Wang J, Zheng H, Ou X, et al. Deficiency of microvascular thrombomodulin and up-regulation of protease-activated receptor-1 in irradiated rat intestine: possible link between endothelial dysfunction and chronic radiation fibrosis. Am J Pathol 2002;160:2063-72.